| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
MediWound Ltd (NASDAQ: MDWD)
MDWD Technical Analysis
5
| As on 17th Jun 2025 MDWD STOCK Price closed @ 19.78 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 16.08 & Strong Buy for SHORT-TERM with Stoploss of 12.39 we also expect STOCK to react on Following IMPORTANT LEVELS. |
MDWDSTOCK Price
| Open | 20.25 | Change | Price | % |
| High | 20.71 | 1 Day | -0.71 | -3.47 |
| Low | 19.78 | 1 Week | -1.82 | -8.43 |
| Close | 19.78 | 1 Month | 2.07 | 11.69 |
| Volume | 38913 | 1 Year | 9.25 | 87.84 |
| 52 Week High 22.24 | 52 Week Low 10.17 | ||||
NASDAQ USA Most Active Stocks
| AMRS | 0.14 | 100.00% |
| PCSA | 0.26 | 13.04% |
| GNLN | 0.01 | 0.00% |
| ACXP | 0.82 | 164.52% |
| HCTI | 0.02 | -33.33% |
| LCID | 2.15 | 0.00% |
| NVDA | 144.12 | -0.39% |
| LMDX | 0.02 | 0.00% |
| RUN | 5.78 | -40.04% |
| AKTS | 0.04 | 0.00% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| MDWD Daily Charts |
MDWD Intraday Charts |
Whats New @ Bazaartrend |
MDWD Free Analysis |
|
|
MDWD Important Levels Intraday
| RESISTANCE | 21.57 |
| RESISTANCE | 21.00 |
| RESISTANCE | 20.64 |
| RESISTANCE | 20.29 |
| SUPPORT | 19.27 |
| SUPPORT | 18.92 |
| SUPPORT | 18.56 |
| SUPPORT | 17.99 |
MDWD Forecast June 2025
| 4th UP Forecast | 24.69 |
| 3rd UP Forecast | 23.12 |
| 2nd UP Forecast | 22.14 |
| 1st UP Forecast | 21.17 |
| 1st DOWN Forecast | 18.39 |
| 2nd DOWN Forecast | 17.42 |
| 3rd DOWN Forecast | 16.44 |
| 4th DOWN Forecast | 14.87 |
MDWD Weekly Forecast
| 4th UP Forecast | 21.11 |
| 3rd UP Forecast | 20.68 |
| 2nd UP Forecast | 20.42 |
| 1st UP Forecast | 20.16 |
| 1st DOWN Forecast | 19.40 |
| 2nd DOWN Forecast | 19.14 |
| 3rd DOWN Forecast | 18.88 |
| 4th DOWN Forecast | 18.45 |
MDWD Forecast2025
| 4th UP Forecast | 46.64 |
| 3rd UP Forecast | 38.03 |
| 2nd UP Forecast | 32.7 |
| 1st UP Forecast | 27.38 |
| 1st DOWN Forecast | 12.18 |
| 2nd DOWN Forecast | 6.86 |
| 3rd DOWN Forecast | 1.53 |
| 4th DOWN Forecast | -7.08 |
MediWound Ltd ( NASDAQ USA Symbol : MDWD )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
MDWD Business Profile
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; MWPC005, a topically applied biological drug candidate that is in Phase I/II clinical trial for the treatment of non-melanoma skin cancers; and MWPC003 for connective tissue disorders. MediWound Ltd. was founded in 2000 and is headquartered in Yavne, Israel. Address: 42 Hayarkon Street, Yavne, Israel, 8122745
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service